Disease Modeling

Axol has over 60 different patient disease lines in stock. If you want to reliably model diseases like Alzheimer’s, Parkinson’s or ALS using human iPSC-derived cells in a dish, browse our catalog to see which lines have the genetic backgrounds and Isogenic controls to suit your needs. We provide fully defined differentiated cells from these disease lines.
Axol-Bioscience-human-iPSC-image-frame.svg

iPSC Research Spotlight

Scientists around the world are using iPSCs for innovative research

Axol-Bioscience-human-iPSC-image-image1-min.png

Selina Wray, Alzheimer’s Research UK

We spoke with Selina Wray, Professor of Molecular Neuroscience and Alzheimer’s Research UK Senior Research Fellow in the Department of Neurodegenerative Disease at UCL Queen Square Institute of Neurology, London.

Selina explained how developing in vitro models of Alzheimer’s Disease using iPSC’s derived from patient cells will improve translation of therapies to the clinic for the treatment of this neurodegenerative disease.

Application Request


Human iPSC-derived disease lines from patient donors

Human iPSC-derived neural stem cells from healthy donors

Protocols & Application Notes

Applications

Axol-Bioscience-human-iPSC-image-glitter-bg-01.jpg

Assay Development

Axol’s iPSC-derived cells are robust and reproducibly made, making them the perfect tool for your assay development requirements.

Axol-Bioscience-human-iPSC-image-glitter-bg-01.jpg

Co-Culture Models

Axol’s iPSC-derived cells can be grown in co-culture to provide a more physiologically relevant scenario for cellular development and function.

Axol Services

No results found.